m+Medelevator.RU
← Поиск публикаций
Updates in surgery · 2025

Standardization of a novel serosal patching technique with Glubran®2 in robot-assisted distal pancreatectomy: operative technique and initial outcomes.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Mahamid Ahmad, Essami Nabih, Haddad Riad

Аннотация

Clinically relevant postoperative pancreatic fistula (CR-POPF) is a primary cause of morbidity after distal pancreatectomy (DP). Current stump reinforcement techniques yield inconsistent results. We previously reported promising initial results with a novel Glubran®2 serosal patching (GSP) technique. This study aims to report outcomes from an expanded series using a standardized GSP methodology. This is a single-center retrospective analysis of 10 consecutive patients who underwent robot-assisted distal pancreatectomy (DP) with standardized GSP for pancreatic stump closure. The primary outcome was the incidence of CR-POPF (Grades B/C) within 90 days, defined according to the International Study Group on Pancreatic Surgery (ISGPS) criteria. Secondary outcomes included overall morbidity and mortality. Ten patients (mean age 71.6 ± 5.4 years; 60% male) were included. The mean operative time was 4.8 ± 1.1 h, and all procedures achieved R0 resection. The mean length of stay was 5.1 ± 2.2 days. The incidence of CR-POPF was 0%. One patient (10%) developed a biochemical leak (formerly Grade A) that resolved without intervention. No major complications (Clavien-Dindo Grade ≥ IIIa) or 90-day mortality occurred. The standardized application of the GSP technique for pancreatic stump closure after robot-assisted DP appears to be a safe and reproducible method. In this small, consecutive series, the technique was associated with a complete absence of clinically relevant pancreatic fistulae; however, these preliminary outcomes must be interpreted with caution. This novel technique shows promise, and its efficacy warrants further investigation in larger, prospective trials.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты